This morning, Pfizer announced that its off-patent medicines company, Upjohn, will merge with generic drugmaker Mylan to form a new pharmaceutical company with projected 2020 revenues of up to $20 billion. The potential merger of the companies has been teased…
Simple on the Surface, Complex Underneath: Lessons from a Real-World Trial
Trying to make a real-world data study as easy as possible for practitioners and participants requires a great deal of work behind the scenes, experts say, but careful planning pays off. Representatives of GlaxoSmith Kline’s Salford Lung Study (SLS) say…
Global Regulatory & Consumer Insights (GRCIS) is going Global
On completion of three years of operations, Global Regulatory & Consumer Insights (GRCIS) has opened it’s first overseas office in Ontario, Canada. The team is excited to face a new challenges and a new landscape. Canada is widely regarded as…
Will Google and Apple Compete for Clinical Trial Dominance?
Google officially entered the clinical space with the launch of their Verily Study Watch last month. One of their driving goals with this device is to help researchers passively capture human health data. Among other things, Verily will use the…
Elon Musk Sees His Neuralink Merging Your Brain With A.I.
Elon Musk said startup Neuralink, which aims to build a scalable implant to connect human brains with computers, has already implanted chips in rats and plans to test its brain-machine interface in humans within two years, with a long-term goal…
Novotech CRO Partners Skin Research Institute
Novotech, an Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in skin research…
Roche and Novo Nordisk Top Clinical Trial Transparency Survey
In its third installment of the Good Pharma Scorecard, Roche and Novo Nordisk scored perfect marks in overall trial transparency, while Johnson & Johnson slipped from the high spot on the previous ranking. The Good Pharma Scorecard, developed by Connecticut-based…
U.S Market is not for Biosimilars, Analysis shows
Over the past several years, the U.S. Food and Drug Administration has approved a number of biosimilar medications, therapies that have similar properties to a branded drug, but are different in composition, which differentiates them from generic drugs. The approval…
Novartis, Amgen and Banner End Alzheimer’s Program After Analysis Shows Patients’ Conditions Worsening
Another one bites the dust as Novartis, Amgen and the Banner Alzheimer’s Instituteannounced they are halting two pivotal Phase II/III clinical trials in the Alzheimer’s Prevention Initiative Generation Program. The trials were evaluating the BACE1 inhibitor CNP520 (umibecestat). An analysis…
UnitedHealth Group Acquires PatientsLikeMe
July 8, 2019 | UnitedHealth Group has acquired online patient community portal PatientsLikeMe as of June 19. As part of the acquisition, the startup will now become part of UnitedHealth Group’s research arm that focuses on healthcare improvements and innovation. In…
